Decreasing mortality in severe sepsis and septic shock patients by implementing a sepsis bundle in a hospital setting

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Shiramizo, Sandra Christina Pereira Lima ^a   Marra, Alexandre R ^a   Durão, Marcelino S ^a   Paes, Ângela T ^a   Edmond, Michael B ^b   dos Santos, Oscar Fernando Pavão ^a  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTIBIOTIC AGENT; CORTICOSTEROID; GLUCOSE; HYDROCORTISONE; HYPERTENSIVE FACTOR; LACTIC ACID;

ADULT; AGE; APACHE; ARTERIAL BLOOD; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CULTURE; BLOOD OXYGEN TENSION; CENTRAL VENOUS OXYGEN SATURATION; CENTRAL VENOUS PRESSURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLUID RESUSCITATION; GLUCOSE BLOOD LEVEL; HEART DISEASE; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; LACTATE BLOOD LEVEL; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; QUASI EXPERIMENTAL STUDY; RESPIRATORY FAILURE; RESUSCITATION; RISK FACTOR; SEPSIS; SEPTIC SHOCK; AGED; HOSPITAL; MIDDLE AGED;

AGED; AGED, 80 AND OVER; FEMALE; GUIDELINE ADHERENCE; HOSPITALS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; SEPSIS; SHOCK, SEPTIC;

EID: 80455158133     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026790     Document Type: Article

References (22)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310.
2. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368-1377.
3. Silva E, Pedro MA, Sogayar AC, Mohovic T, Silva CL, et al. (2004) Brazilian Sepsis Epidemiological Study (BASES study). Crit Care 8: R251-260.
4. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, et al. (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32: 858-873.
5. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, et al. (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 30: 536-555.
6. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-1655.
7. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, et al. (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36: 296-327.
8. Nguyen HB, Corbett SW, Steele R, Banta J, Clark RT, et al. (2007) Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care 35: 1105-1112.
9. De Miguel-Yanes JM, Munoz-Gonzalez J, Andueza-Lillo JA, Moyano-Villaseca B, Gonzalez-Ramallo VJ, et al. (2009) Implementation of a bundle of actions to improve adherence to the Surviving Sepsis Campaign guidelines at the ED. Am J Emerg Med 27: 668-674.
10. Peake SL, Bailey M, Bellomo R, Cameron PA, Cross A, et al. (2009) Australasian resuscitation of sepsis evaluation (ARISE): A multi-centre, prospective, inception cohort study. Resuscitation 80: 811-818.
11. Becker JU, Theodosis C, Jacob ST, Wira CR, Groce NE, (2009) Surviving sepsis in low-income and middle-income countries: new directions for care and research. Lancet Infect Dis 9: 577-582.
12. Ferrer R, Artigas A, Levy MM, Blanco J, Gonzalez-Diaz G, et al. (2008) Improvement in process of care and outcome after a multicenter severe sepsis education program in Spain. JAMA 299: 2294-2303.
13. Castellanos-Ortega A, Suberviola B, Garcia-Astudillo LA, Holanda MS, Ortiz F, et al. (2010) Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study. Crit Care Med 38: 1036-1043.
14. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, et al. (2010) Results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 38: 367-374.
15. Trzeciak S, Dellinger RP, Abate NL, Cowan RM, Stauss M, et al. (2006) Translating research to clinical practice- A 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest 129: 225-232.
16. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef M, (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118: 9-11.
17. Zaragoza R, Artero A, Camarena JJ, Sancho S, Gonzalez R, et al. (2003) The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect 9: 412-418.
18. Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, et al. (2003) Pseudomonas aeruginosa bacteremia: Risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 37: 745-751.
19. Marra AR, Cal RG, Silva CV, Caserta RA, Paes AT, et al. (2009) Successful prevention of ventilator-associated pneumonia in an intensive care setting. Am J Infect Control 37: 619-625.
20. Marra AR, Cal RG, Durão MS, Correa L, Guastelli LR, et al. (2010) Impact of a program to prevent central line-associated bloodstream infection in the zero tolerance era. Am J Infect Control 38: 434-439.
21. Durao MS, Marra AR, Moura DF, Almeida SM, Fernandes CJ, et al. (2010) Tight glucose control versus intermediate glucose control: a quasi-experimental study. Anaesth Intensive Care 38: 1-7.
22. Finfer S, Chittock DR, Su SY, Blair D, Foster D, et al. (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med; 360: 1283-1297.